Not medical advice. This site is general information only. In an emergency call your local emergency number. For advice about your own health, speak to a doctor, pharmacist or other qualified health professional.

Mycophenolate

Immunosuppressant1995
Drug ClassImmunosuppressant
Year Approved1995
Conditions TreatedOrgan transplant, autoimmune
AvailabilityPrescription

About Mycophenolate

An immunosuppressant that inhibits purine synthesis in lymphocytes. Mycophenolate or CellCept prevents organ transplant rejection and treats autoimmune conditions including lupus nephritis. It selectively targets lymphocytes because these cells depend on de novo purine synthesis. Mycophenolate has replaced azathioprine in most transplant protocols. Side effects include gastrointestinal problems, low blood counts, and increased infection risk. The drug is teratogenic and contraindicated in pregnancy.

Related Medications